Why the study?
Does very-low-intensity oral anticoagulation (INR 1.4 to 2.0) prevent thromboses as effectively as standard low-intensity oral anticoagulation (INR 2.0 to 3.0)?
Does very-low-intensity oral anticoagulation (INR 1.4 to 2.0) prevent thromboses as effectively as standard low-intensity oral anticoagulation (INR 2.0 to 3.0)?
Very-low-intensity oral anticoagulation (INR 1.4 to 2.0) appears to be as effective as standard low-intensity anticoagulation (INR 2.0 to 3.0) in preventing thromboses without a significant difference in major complications.
Answers are grounded in this paper and cite their sources.
Very-low-intensity anticoagulation was associated with similar complication rates; leaves open noninferiority for thrombosis prevention in observational data.
We compared the efficacy of very-low-intensity oral anticoagulation (OA) with that of the recommended standard low-intensity oral anticoagulation, using international normalized ratios (INRs). We enrolled 101 patients into a pilot study--51 patients in the very-low-intensity anticoagulation arm (INR 1.4 to 2.0) and 50 in the standard low-intensity anticoagulation arm (INR 2.0 to 3.0). They were monitored for thrombotic/embolic and hemorrhagic complications for an average follow-up of 1.5 years. Two thrombotic/embolic events occurred in the very-low-intensity group; no thrombotic/embolic events occurred in the standard low-intensity group. No major bleeding occurred in the very-low-intensity group; one major hemorrhagic event occurred in the standard low-intensity group. These findings did not achieve a statistically significant difference in major complications between the two groups. It appears that very-low-intensity OA (INR 1.4 to 2.0) is as effective in preventing thromboses as standard low-intensity OA (INR 2.0 to 3.0).
No takes yet. Share an insight, caveat, or question.
KLEIN et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: